Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Servier's partner Amgen receives FDA authorization for heart failure drug

Les Laboratoires Servier, a French pharmaceutical company, has announced that its partner, Amgen Inc., a biotechnology company, has received marketing authorization from the FDA for CORLANOR, or ivabradine, indicated for the treatment of chronic heart failure, or CHF.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Honeywell Aerospace expands relationship with Celestica

Celestica Inc. has announced that Honeywell Aerospace has subcontracted to Celestica final assembly and test, and repair and overhaul, or R&O, for certain product lines, including electric power, and air and thermal management systems at Honeywell's facility in Mississauga, Ontario, Canada.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Jacobs receives two-year framework agreement from MODON

Jacobs Engineering Group Inc. has received a two-year framework agreement from Saudi Industry Property Authority, or MODON, for supervision consultancy services to support the development of three industrial cities in Saudi Arabia.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Momenta announces FDA approval for Sandoz's multiple sclerosis drug

Momenta Pharmaceuticals, Inc., a biotechnology company, has announced that the FDA has granted marketing approval for Sandoz's abbreviated new drug application, or ANDA, for Glatopa 20mg/mL, a once daily, generic equivalent of COPAXONE 20mg, indicated for the treatment of multiple sclerosis.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Perrigo receives approval for generic version of dermatoses drug in US

Perrigo Company plc, a manufacturer of generic drugs, has received Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Barco announces five year agreement with 20th Century Fox

Barco and 20th Century Fox have announced a five year, multi-title agreement to release movies in Barco's multi-screen, movie format Barco Escape.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Thermo Fisher Scientific introduces new range of single-use mixers

Thermo Fisher Scientific Inc., an American biotechnology product development company, has introduced the Thermo Scientific HyPerforma Single-Use Mixers, or SUM, a new range of single-use mixers.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Teck Resources Q1 profit decreases

Teck Resources Limited, a Canadian metals and mining company, has reported that profit attributable to shareholders of the company for the first quarter ended March 31, 2015 was C$68 million, or C$0.12 per share, compared to C$69 million, or C$0.12 per share, for the same quarter ended March 31, 2014.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Brinker International Q3 net income increases

Brinker International, Inc. has reported that net income for the third quarter ended March 25, 2015 was $65.43 million, or $1.02 per diluted share, compared to $56.26 million, or $0.82 per diluted share, for the same quarter ended March 26, 2014.

Published By MarketLine
23 Apr 2015
NewsWire
NewsWire

Takeda Pharmaceutical and CiRA collaborate for iPS research

Takeda Pharmaceutical Company Limited and the Center for iPS Cell Research Application, or CiRA, of Kyoto University have collaborated to develop clinical applications of induced pluripotent stem, or iPS, cells in areas such as heart failure, diabetes mellitus, neurological disorders and cancer immunotherapy.

Published By MarketLine
23 Apr 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.